Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.

KJ Muldoon recently made history by becoming the first patient to receive a personalized CRISPR gene therapy, designed specifically for the genetic mutations causing his rare metabolic disease. | KJ ...

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

On World Bioproduct Day, Dr. Jitendra Singh reaffirmed India’s goal of achieving a $300 billion bioeconomy by 2030. He emphasized inclusive participation, sustainable innovation, and grassroots ...

The gene-editing platform known as Crispr is widely used by researchers in scientific laboratories in their search for new ...

R are genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend ...

CRISPR Therapeutics could stage a comeback thanks to clinical and commercial progress. There are many promising corporations ...

CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Victoria Gray is the first person in the world to receive CRISPR,  a gene-editing therapy for sickle cell disease created by Dr. Jennifer Doudna who won the Nobel Prize for the life saving technology.

Nobel Prize winners convince court to revive CRISPR patent dispute By Blake Brittain May 12, 20252:43 PM PDTUpdated May 12, 2025 ...

University of California, Berkeley biochemist Jennifer Doudna won the 2020 Nobel Prize in Chemistry alongside Emmanuelle Charpentier for their pioneering work on CRISPR-Cas9. This revolutionary ...